Repetitive Transcranial Magnetic Stimulation as an Alternative Therapy for Cognitive Impairment in Alzheimer's Disease: A Meta-Analysis

Journal of Alzheimer's Disease

Volumn 48, Issue 2, 2015, Pages 463-472

  Liao, Xiang ^a   Li, Guangming ^a   Wang, Anguo ^a   Liu, Tao ^a   Feng, Shenggang ^a   Guo, Zhiwei ^a   Tang, Qing ^a   Jin, Yu ^a,b   Xing, Guoqiang ^c   McClure, Morgan A ^a   Chen, Huaping ^a   He, Bin ^a   Liu, Hua ^a   Mu, Qiwen ^a,d  

^a Pre Clinical College   (China)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

^c Lotus Biotechcom LLC   (United States)

^d PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Alzheimer's disease; meta analysis; mild to moderate cognitive impairment; repetitive transcranial magnetic stimulation

Indexed keywords

ALTERNATIVE MEDICINE; ALZHEIMER DISEASE; ARTICLE; COGNITION; DORSOLATERAL PREFRONTAL CORTEX; HEMISPHERE; HUMAN; INFERIOR FRONTAL GYRUS; META ANALYSIS; MILD COGNITIVE IMPAIRMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUPERIOR TEMPORAL GYRUS; SYSTEMATIC REVIEW; TRANSCRANIAL MAGNETIC STIMULATION; COGNITION DISORDERS; COMPLICATION; PATHOPHYSIOLOGY; PROCEDURES;

ALZHEIMER DISEASE; COGNITION DISORDERS; HUMANS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84941267798     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150346     Document Type: Article

References (57)

1. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, Willis RJ, Wallace RB (2007) Prevalence of dementia in the United States: The aging, demographics, and memory study. Neuroepidemiology 29, 125-132.
2. Kumar A, Singh A, Ekavali (2015) A review on Alzheimer's disease pathophysiology and its management: An update. Pharmacol Rep 67, 195-203.
3. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3, 186-191.
4. Anand R, Gill KD, Mahdi AA (2014) Therapeutics of Alzheimer's disease: Past, present and future. Neuropharmacology 76 Pt A, 27-50.
5. Heron M (2013) Deaths: Leading causes for 2010. National Vital Statistics Reports; vol. 62, no 6. National Center for Health Statistics, Hyattsville, MD.
6. Hebert LE, Weuve J, Scherr PA, Evans DL (2013) Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 80, 1778-1783.
7. Geldmacher DS, Whitehouse PJ Jr (1997) Differential diagnosis of Alzheimer's disease. Neurology 48, S2-S9.
8. Alzheimer's, Association (2014) 2014 Alzheimer's disease facts and figures. Alzheimers Dement 10, e47-e92.
9. Perry EK, Perry RH, Blessed G, Tomlinson BE (1977) Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1, 189.
10. Giacobini E (1990) The cholinergic system in Alzheimer disease. Prog Brain Res 84, 321-332.
11. Beach TG, Kuo YM, Spiegel K, Emmerling MR, Sue LI, Kokjohn K, Roher AE (2000) The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer disease. J Neuropathol Exp Neurol 59, 308-313.
12. Rogers SL, Friedhoff LT (1996) The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebocontrolled trial. The Donepezil Study Group. Dementia 7, 293-303.
13. Birks J (2006) Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev, CD005593.
14. Birks J, Grimley Evans J, Iakovidou V, Tsolaki M, Holt FE (2009) Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev, CD001191.
15. Mecocci P, Bladstrom A, Stender K (2009) Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease:Post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, doubleblind, placebo-controlled studies. Int J Geriatr Psychiatry 24, 532-538.
16. Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E, Edwards S, Hardyman W, Raftery J, Crome P, Lendon C, Shaw H, Bentham P, Group ADC (2004) Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): Randomised double-blind trial. Lancet 363, 2105-2115.
17. Spector A, Thorgrimsen L, Woods B, Royan L, Davies S, Butterworth M, Orrell M (2003) Efficacy of an evidencebased cognitive stimulation therapy programme for people with dementia: Randomised controlled trial. Br J Psychiatry 183, 248-254.
18. Foerster S, Buschert VC, Buchholz HG, Teipel SJ, Zach C, Bartenstein P (2009) Positive effects of a 6-month stagespecific cognitive intervention program on brain metabolism in subjects with amnestic mild cognitive impairment (aMCI) and mild Alzheimer's Disease (AD). Alzheimers Dement 5, 38.
19. Sitzer DI, Twamley EW, Jeste DV (2006) Cognitive training in Alzheimer's disease:Ameta-analysis of the literature. Acta Psychiatr Scand 114, 75-90.
20. Anderkova L, Rektorova I (2014) Cognitive effects of repetitive transcranial magnetic stimulation in patients with neurodegenerative diseases - clinician's perspective. J Neurol Sci 339, 15-25.
21. Freitas C, Mondragon-Llorca H, Pascual-Leone A (2011) Noninvasive brain stimulation in Alzheimer's disease: Systematic review and perspectives for the future. Exp Gerontol 46, 611-627.
22. Guse B, Falkai P, Wobrock T (2010) Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: A systematic review. J Neural Transm 117, 105-122.
23. Cotelli M, Manenti R, Cappa SF, Zanetti O, Miniussi C (2008) Transcranial magnetic stimulation improves naming in Alzheimer disease patients at different stages of cognitive decline. Eur J Neurol 15, 1286-1292.
24. Thiel A, Hartmann A, Rubi-Fessen I, Anglade C, Kracht L, Weiduschat N, Kessler J, Rommel T, Heiss WD (2013) Effects of noninvasive brain stimulation on language networks and recovery in early poststroke aphasia. Stroke 44, 2240-2246.
25. Turriziani P, Smirni D, Zappala G, Mangano GR, Oliveri M, Cipolotti L (2012) Enhancing memory performance with rTMS in healthy subjects and individuals with Mild Cognitive Impairment: The role of the right dorsolateral prefrontal cortex. Front Hum Neurosci 6, 62.
26. Barker AT, Jalinous R, Freeston IL (1985) Non-invasive magnetic stimulation of human motor cortex. Lancet 1, 1106-1107.
27. Hsu WY, Cheng CH, Liao KK, Lee IH, Lin YY (2012) Effects of repetitive transcranial magnetic stimulation on motor functions in patients with stroke: A meta-analysis. Stroke 43, 1849-1857.
28. Cao L, Zhao R, Huo S, Du JB, Liu L, Zhang YM, Song WQ (2014) Effects of repetitive transcranial magnetic stimulation on cognitive impairment in stroke patients: A meta-analysis. Mol Neurobiol. doi: 10.1007/s12035-014-8895-2
29. Liu B, Zhang Y, Zhang L, Li L (2014) Repetitive transcranial magnetic stimulation as an augmentative strategy for treatment-resistant depression, a meta-analysis of randomized, double-blind and sham-controlled study.BMCPsychiatr 14, 342.
30. Valle AC, Dionisio K, Pitskel NB, Pascual-Leone A, Orsati F, Ferreira MJ, Boggio PS, Lima MC, Rigonatti SP, Fregni F (2007) Low and high frequency repetitive transcranial magnetic stimulation for the treatment of spasticity. Dev Med Child Neurol 49, 534-538.
31. Nakamura H, Kitagawa H, Kawaguchi Y, Tsuji H (1997) Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans. J Physiol 498(Pt 3), 817-823.
32. Sasaki N, Kakuda W, Abo M (2014) Bilateral high- and lowfrequency rTMS in acute stroke patients with hemiparesis: A comparative study with unilateral high-frequency rTMS. Brain Inj 28, 1682-1686.
33. Kim BR, Kim DY, Chun MH, Yi JH, Kwon JS (2010) Effect of repetitive transcranial magnetic stimulation on cognition and mood in stroke patients: A double-blind, sham-controlled trial. Am J Phys Med Rehabil 89, 362-368.
34. Levkovitz Y, Isserles M, Padberg F, Lisanby SH, Bystritsky A, Xia G, Tendler A, Daskalakis ZJ, Winston JL, Dannon P, Hafez HM, Reti IM, Morales OG, Schlaepfer TE, Hollander E, Berman JA, Husain MM, Sofer U, Stein A, Adler S, Deutsch L, Deutsch F, Roth Y, George MS, Zangen A (2015) Efficacy and safety of deep transcranial magnetic stimulation for major depression: A prospective multicenter randomized controlled trial. World Psychiatry 14, 64-73.
35. Cotelli M, Manenti R, Cappa SF, Geroldi C, Zanetti O, Rossini PM, Miniussi C (2006) Effect of transcranial magnetic stimulation on action naming in patients with Alzheimer disease. Arch Neurol 63, 1602-1604.
36. Bentwich J, Dobronevsky E, Aichenbaum S, Shorer R, Peretz R, Khaigrekht M, Marton RG, Rabey JM (2011) Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease: A proof of concept study. J Neural Transm 118, 463-471.
37. Cotelli M, Calabria M, Manenti R, Rosini S, Zanetti O, Cappa SF, Miniussi C (2011) Improved language performance in Alzheimer disease following brain stimulation. J Neurol Neurosurg Psychiatry 82, 794-797.
38. Eliasova I, Anderkova L, Marecek R, Rektorova I (2014) Noninvasive brain stimulation of the right inferior frontal gyrus may improve attention in early Alzheimer's disease: A pilot study. J Neurol Sci 346, 318-322.
39. Ahmed MA, Darwish ES, Khedr EM, El Serogy YM, Ali AM (2012) Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer's dementia. J Neurol 259, 83-92.
40. Rabey JM, Dobronevsky E, Aichenbaum S, Gonen O, Marton RG, Khaigrekht M (2013) Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: A randomized, double-blind study. J Neural Transm 120, 813-819.
41. Zintzaras E, Ioannidis JP (2005) HEGESMA: Genome search meta-analysis and heterogeneity testing. Bioinformatics 21, 3672-3673.
42. Schmidt FL, Oh IS, Hayes TL (2009) Fixed- versus random-effects models in meta-analysis: Model properties and an empirical comparison of differences in results. Br JMath Stat Psychol 62, 97-128.
43. Nardone R, Tezzon F, Holler Y, Golaszewski S, Trinka E, Brigo F (2014) Transcranial magnetic stimulation (TMS)/repetitive TMS in mild cognitive impairment and Alzheimer's disease. Acta Neurol Scand 129, 351-366.
44. Trojano L, Conson M, Maffei R, Grossi D (2006) Categorical and coordinate spatial processing in the imagery domain investigated by rTMS. Neuropsychologia 44, 1569-1574.
45. Haffen E, Chopard G, Pretalli JB, Magnin E, Nicolier M, Monnin J, Galmiche J, Rumbach L, Pazart L, Sechter D, Vandel P (2012) A case report of daily left prefrontal repetitive transcranial magnetic stimulation (rTMS) as an adjunctive treatment for Alzheimer disease. Brain Stimul 5, 264-266.
46. Wagner T, Valero-Cabre A, Pascual-Leone A (2007) Noninvasive human brain stimulation. Annu Rev Biomed Eng 9, 527-565.
47. Zheng XM (2000) Regional cerebral blood flow changes in drug-resistant depressed patients following treatment with transcranial magnetic stimulation: A statistical parametric mapping analysis. Psychiatry Res 100, 75-80.
48. Bliss TV, Collingridge GL (1993) A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 361, 31-39.
49. Koch G, Di Lorenzo F, Bonni S, Ponzo V, Caltagirone C, Martorana A (2012) Impaired LTP-but not LTD-like cortical plasticity in Alzheimer's disease patients. J Alzheimers Dis 31, 593-599.
50. Potter-Nerger M, Fischer S, Mastroeni C, Groppa S, Deuschl G, Volkmann J, Quartarone A, Munchau A, Siebner HR (2009) Inducing homeostatic-like plasticity in human motor cortex through converging corticocortical inputs. J Neurophysiol 102, 3180-3190.
51. Kimbrell TA, Little JT, Dunn RT, Frye MA, Greenberg BD, Wassermann EM, Repella JD, Danielson AL, Willis MW, Benson BE, Speer AM, Osuch E, George MS, Post RM (1999) Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry 46, 1603-1613.
52. Bai F, Zhang Z, Watson DR, Yu H, Shi Y, Yuan Y, Zang Y, Zhu C, Qian Y (2009) Abnormal functional connectivity of hippocampus during episodic memory retrieval processing network in amnestic mild cognitive impairment. Biol Psychiatry 65, 951-958.
53. Sperling RA, Dickerson BC, Pihlajamaki M, Vannini P, LaViolette PS, Vitolo OV, Hedden T, Becker JA, Rentz DM, Selkoe DJ, Johnson KA (2010) Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med 12, 27-43.
54. Wang L, Zang Y, He Y, Liang M, Zhang X, Tian L, Wu T, Jiang T, Li K (2006) Changes in hippocampal connectivity in the early stages of Alzheimer's disease: Evidence from resting state fMRI. Neuroimage 31, 496-504.
55. Grady CL, McIntosh AR, Beig S, Keightley ML, Burian H, Black SE (2003) Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease. J Neurosci 23, 986-993.
56. Smith GE, Pankratz VS, Negash S, Machulda MM, Petersen RC, Boeve BF, Knopman DS, Lucas JA, Ferman TJ, Graff-Radford N, Ivnik RJ (2007) A plateau in pre-Alzheimer memory decline: Evidence for compensatory mechanisms? Neurology 69, 133-139.
57. Sole-Padulles C, Bartres-Faz D, Junque C, Clemente IC, Molinuevo JL, Bargallo N, Sanchez-Aldeguer J, Bosch B, Falcon C, Valls-Sole J (2006) Repetitive transcranial magnetic stimulation effects on brain function and cognition among elders with memory dysfunction. Arandomized shamcontrolled study. Cereb Cortex 16, 1487-1493.